Disc Medicine, Inc. — Director's Dealing 2021

Feb 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemini Therapeutics, Inc. /DE (GMTX)
CIK: 0001816736
Period of Report: 2021-02-05

Reporting Person: FS Development Holdings, LLC (10% Owner, Director by Deputization)
Reporting Person: Foresite Capital Fund V, L.P. (10% Owner, Director by Deputization)
Reporting Person: Foresite Capital Management V, LLC (10% Owner, Director by Deputization)
Reporting Person: Foresite Capital Opportunity Fund V, L.P. (10% Owner, Director by Deputization)
Reporting Person: Foresite Capital Opportunity Management V, LLC (10% Owner, Director by Deputization)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-05	Common Stock	A	1500000	$10.00	Acquired	1500000	Direct
2021-02-05	Common Stock	C	2928750	—	Acquired	2928750	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-05	Common Stock	$0	C	2928750	Disposed		Common Stock (2928750)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	441500	Direct

Footnotes

F1: Shares of common stock obtained in private placement of public securities ("PIPE") on February 5, 2021.

F2: These shares of the Issuer's common stock are held of record by FS Development Holdings, LLC ("FSD Holdings"). Foresite Capital Management V LLC ("FCMVLLC") and Foresite Capital Opportunity Management V, LLC ("FCOMVLLC") are general partners, respectively, of Foresite Capital Fund V, L.P. ("Capital Fund V L.P.") and Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V .L.P."), the sole shareholders of FSD Holdings. Each of FCMVLLC, FCOMVLLC, Capital Fund V L.P and Opportunity Fund V L.P. disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.

F3: In connection with the closing of Gemini Therapeutics, Inc.'s (formerly known as FS Development Corp.) business combination, shares of Class B Common Stock of FS Development Corp. converted into common stock of the Issuer .